Liquid biopsies offer a non-invasive way to detect and monitor breast cancer through a simple blood test. By identifying circulating tumor DNA in the blood, doctors can detect cancer at an early stage, monitor how a tumor is responding to treatment, and detect any signs of recurrence. This innovation enables more timely interventions and a less invasive way for patients to manage their condition.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.